Drug factory · FDA FEI 1937815

R.D. Laboratories, Inc.

204 Lange Drive, Washington, MO, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 26, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2010: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AbametapirTests it Dr. Reddy's Laboratories Inc. 43598-921
OxcarbazepineTests it Ajanta Pharma USA Inc. 27241-304, 27241-305, 27241-306

FDA inspection history

EndedResultProgramProblems noted
Jan 26, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 27, 2021Problems found, fixed voluntarilyDrug Quality Assurance4
Nov 2, 2016No problems foundDrug Quality Assurance—
Apr 8, 2014No problems foundDrug Quality Assurance—
Oct 5, 2011No problems foundDrug Quality Assurance—
Jan 6, 2010No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Aug 27, 2021 inspection

Registered with FDA for: analysis.